Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Neoral, Gengraf, Sandimmune
Cyclosporin is an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It has been studied in transplants of skin, heart, kidney, lung, pancreas, bone marrow and small intestine.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Prevent organ rejection | 147 | 13 |
|
|
|
||
| Transplant rejection prevention | 86 | 24 |
|
|
|
||
| Kidney Transplant | 5 | 0 | |||||
| Kidney Transplant | 4 | 1 |
|
||||
| Other | 3 | 0 | |||||
| Psoriasis | 3 | 1 |
|
See all 223 patients currently taking Cyclosporine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Cyclosporine
| Hair growth | 7 | |
|---|---|---|
| Elevated blood pressure | 3 | |
| Weight gain | 2 | |
| Nausea | 2 | |
| Facial hair excessive | 2 | |
| Hair growth increased | 2 | |
| See all 62 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Cyclosporine. See all 38 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 35 | ||
| Side effects too severe | 18 | ||
| Did not seem to work | 11 | ||
| Other | 9 | ||
| Course of treatment ended | 5 | ||
| Personal research | 3 | ||
| Expense | 1 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Cyclosporine
Always |
36 | 86% |
|
|---|---|---|---|
Usually |
6 | 14% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Cyclosporine
Very |
2 | 5% |
|
|---|---|---|---|
Somewhat |
3 | 7% |
|
A little |
13 | 31% |
|
Not at all |
24 | 57% |
|
Cost
Paid out of pocket
Cost of Cyclosporine
$200+ |
5 | 22% |
|
|---|---|---|---|
$100-199 |
2 | 9% |
|
$50-99 |
4 | 17% |
|
$25-49 |
2 | 9% |
|
< $25 |
10 | 43% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 12, 2012.